Riskpilot← Back to searchSign inGet full accessAUXESIS PHARMA HOLDING AB (publ)
ABActiveOrg 5591956486Liljestrands Väg 10 FysiologenResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20195-9 employees
Revenue 2024
SEK 0
EBITDA margin
—
-283% vs 2023
Equity ratio
55.1%
Financial strength
Net profit 2024
SEK -10,3M
-167% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -9,5M | -283% |
| Net profit | SEK -10,3M | -167% |
| Total assets | SEK 15,8M | +4% |
| Equity | SEK 8,7M | +1222% |
| Employees | — | — |
Legal name
AUXESIS PHARMA HOLDING AB (publ)
Org number
5591956486
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20 februari 2019
Share capital
SEK 545 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder Styrelsen ska bestå av 4 styrelseledamöter och 0 styrelsesuppleanter. Registrerad styrelseordförande saknas.
Company purpose
Bolaget skall äga, förvalta och sälja farmaceutiska immateriella rättigheter samt äga och förvalta andelar i andra life science bolag.
Address
Liljestrands Väg 10 Fysiologen
Email
auxesis@auxesispharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 632 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −254 | −5 721 | −2 219 | −2 475 | −9 468 |
| Depreciation & amort. | −0 | −4 | −4 | −7 | −4 |
| EBIT | −254 | −5 725 | −2 223 | −2 482 | −9 472 |
| Net financials | −53 | −6 122 | −1 070 | −3 662 | −826 |
| Profit before tax | −308 | −8 811 | −3 293 | −4 334 | −10 298 |
| Tax | −0 | 1 306 | 779 | 483 | −0 |
| Net profit | −308 | −7 505 | −2 514 | −3 851 | −10 298 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 696 | 13 085 | 13 111 | 15 176 | 15 772 |
| Equity | 70 | 2 454 | 1 408 | 657 | 8 683 |
| Long-term debt | 3 610 | 9 595 | 9 595 | 0 | 0 |
| Short-term debt | 1 016 | 1 035 | 2 108 | 14 519 | 7 090 |
| Total debt | 4 626 | 10 630 | 11 703 | 14 519 | 7 090 |
EBITDA margin
-946800000.0%
This company
15.8%
Market median
-5992405163% vs market
20202024
Equity ratio
55.1%
This company
38.2%
Market median
+44% vs market
20202024
Return on equity
-118.6%
This company
18.4%
Market median
-745% vs market
20202024
Net profit margin
-1029800000.0%
This company
8.1%
Market median
-12713580347% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
RA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 |
LU Chief Executive Officer | Chief Executive Officer | 2025 |
JR Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AUXESIS PHARMA HOLDING AB (publ) 
Acet Medica ABBoard members of AUXESIS PHARMA HOLDING AB (publ) also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Roar Adelsten | Deputy Chief Executive Officer | 0 companies |
| Lars Uno Peter Åberg | Chief Executive Officer | 0 companies |
| Jens Rufus Edlund | Chief Auditor | 0 companies |
| Nils Rune Nordström | Board of Directors | 0 companies |
| Lars Magnus Larsson | Chairman | 0 companies |
| Lars Erik Larsson | Deputy Board Member | 0 companies |
| Moustapha Mohamed Moustapha Hassan | Board of Directors | 0 companies |
| Nina Anna Charlotta Larsson | Board of Directors | 0 companies |